COVID-19 and Cushing's syndrome: recommendations for a special population with endogenous glucocorticoid excess
Rosario Pivonello, Rosario Ferrigno, Andrea M. Isidori, Beverly M. K. Biller, Ashley Grossman, Annamaria Colao
Topics & Concepts
MedicineImmune systemCushing's diseaseDiseaseDiabetes mellitusImmunosuppressionGlucocorticoidImmunologyPopulationMetabolic syndromePandemicInternal medicineEndocrinologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Environmental healthAdrenal Hormones and DisordersPituitary Gland Disorders and TreatmentsNeuroblastoma Research and Treatments